COVID-19 vaccines for children between 2-18 years may become available in India by October

COVID-19 vaccines for children in the age group of 2-18 years may become available in India by October. Director of National Institute of Virology – NIV in Pune, Ms. Priya Abraham has said that results of phase 2 and 3 trials of Covaxin in children will soon be presented to the regulator while Zydus Cadila’s vaccine is also in the pipeline.

It is worth to note that it was NIV that isolated the coronavirus strain and gave it to Bharat Biotech International Limited in April 2020, following which they developed a whole virion-inactivated vaccine, COVAXIN. The Pune based institute also conducted the preclinical trials and helped with the clinical trails in terms of diagnostics and laboratory support.



The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies   

About the author

Avatar photo

The Dispatch Staff

Add Comment

Click here to post a comment